Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioNxt Solutions Inc
C.BNXT
Alternate Symbol(s):
BNXTF
Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active...
pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:BNXT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
(6)
•••
Paleo777
X
View Profile
View Bullboard History
Comment by
Paleo777
on May 04, 2021 8:56pm
RE:RE:Always a new problem or glitch. yada yada
XP Diagnostics will be spun off by year end. XPHY would be smart to retain a controlling interest. youtu.be/8HNKggq4cUw
(2)
•••
Adwari
X
View Profile
View Bullboard History
Comment by
Adwari
on May 04, 2021 2:18pm
RE:Always a new problem or glitch. yada yada
Why did they not submit application of the approval of the Covid-19 rapid PCR kit in Europe, including Israel, USA and Canada etc at the same time, as this would have saved them time. Again it points
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(2)
•••
Adwari
X
View Profile
View Bullboard History
Post by
Adwari
on May 04, 2021 2:11pm
Xphy has great potential but very poor execution- Sad!
Xphy management has executed very badly in spite of enormous potential of their rapid Covid-19 PCR test kit. All news releases put out so far ar futuristic and no concrete sale plans. It is very
...more
(20)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on May 04, 2021 12:26pm
Always a new problem or glitch. yada yada
These clowns have screwed up every step of the way. The 2000 test kits they just sent out will take 90 days to evaluate.
(72)
•••
Franman184
X
View Profile
View Bullboard History
Post by
Franman184
on May 03, 2021 7:23pm
More Translation
Your test has been approved since April, when will you start using it? Sales in Germany are expected to start in May. We have now signed the pharmaceutical wholesaler Max Pharma as a sales partner. In
...more
(2)
•••
Adwari
X
View Profile
View Bullboard History
Comment by
Adwari
on May 03, 2021 9:02am
RE:New article
English Translation: "In the fight against corona, fast PCR tests are the more effective solution " In Germany, what is going on is currently being tested. Unfortunately, the rapid tests are
...more
(55)
•••
FTTHFan
X
View Profile
View Bullboard History
Post by
FTTHFan
on May 02, 2021 10:29pm
New article
https://www.capital.de/wirtschaft-politik/im-kampf-gegen-corona-sind-schnelle-pcr-tests-die-effektivere-loesung
(6)
•••
Paleo777
X
View Profile
View Bullboard History
Comment by
Paleo777
on Apr 27, 2021 10:54am
RE:RE:Targeting European Pharmacies
XPhyto: Why Rapid PCR Testing is Here to Stay | 2021-04-23 | Investing News | Stockhouse The company has been mentioning pharmacies being a target of Covid-ID Lab for a while. My sense is that with
...more
(1)
•••
RDtrade
X
View Profile
View Bullboard History
Comment by
RDtrade
on Apr 26, 2021 9:08am
RE:Targeting European Pharmacies
Paleo can you re post article Link not working Thanks!!
(55)
•••
FTTHFan
X
View Profile
View Bullboard History
Comment by
FTTHFan
on Apr 25, 2021 3:29pm
RE:Targeting European Pharmacies
Nice piece. Thx for posting
(6)
•••
Paleo777
X
View Profile
View Bullboard History
Post by
Paleo777
on Apr 24, 2021 2:51am
Targeting European Pharmacies
Great Article: https://bit.ly/3xu4wvR
(6)
•••
Paleo777
X
View Profile
View Bullboard History
Post by
Paleo777
on Apr 21, 2021 3:54am
Xphyto Signs German Distribution Agreement
XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test : XPhyto Therapeutics Corporation More to come.
(6)
•••
Paleo777
X
View Profile
View Bullboard History
Comment by
Paleo777
on Apr 21, 2021 1:13am
RE:Long winded and useless release imo.
"Long winded and useless release imo." What company doesn't make a public announcement when they appoint a new corporate COO and a new head of business development for their first
...more
(20)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Apr 20, 2021 11:04am
Long winded and useless release imo.
Desperate times call for desperate measures. Get rid of the lawyer.
(6)
•••
Paleo777
X
View Profile
View Bullboard History
Post by
Paleo777
on Apr 20, 2021 5:03am
Executive Appointments
Wolfgang Probst, current managing director of XP Diagnostics is appointed to Chief Operating Officer of Xphyto. Manfred Buchberger, current sales advisor to XPhyto, is appointed to Head of
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden